Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's...
-
Dublin, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The "An Essential Overview of the Pharmaceutical and Biotech Industries Training Course (Mar 12, 2026)" training has been added to ResearchAndMarkets.com's...
-
PITTSBURGH, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Parexel International, LLC (“Parexel”), a clinical research organization based in North Carolina,1 recently experienced a cybersecurity incident,...
-
New York, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will...
-
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Metabolomics-based Nutritional Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
-
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Biobanks Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. ...
-
Science 37 Wins Awards for Excellence in Clinical Trial Delivery, Site Innovation, and Enrollment Acceleration
-
Tekton Research, a leading multi-site clinical trial organization, announced two new research sites in New Carlisle, Ohio, and Englewood, New Jersey.
-
Washington, DC, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Association of Clinical Research Professionals (ACRP) proudly announced that it has been named a Bronze Winner by The 5th Annual Anthem Awards...
-
Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Fully revised...